Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 37,141 | 27,621 | 31,377 | 27,691 | 20,521 |
| Operating Income | -37,141 | -27,621 | -31,377 | -27,691 | -20,521 |
| Other Income | 2,371 | 2,117 | 1,283 | 731 | -85 |
| Pre-tax Income | -34,770 | -25,504 | -30,094 | -26,960 | -20,606 |
| Net Income Continuous | -34,770 | -25,504 | -30,094 | -26,960 | -20,606 |
| Net Income | $-34,770 | $-25,504 | $-30,094 | $-26,960 | $-20,606 |
| EPS Basic Total Ops | -4.04 | -3.04 | -3.60 | -3.15 | -2.70 |
| EPS Basic Continuous Ops | -4.04 | -3.04 | -3.58 | -3.19 | -2.64 |
| EPS Diluted Total Ops | -4.04 | -3.04 | -3.60 | -3.15 | -2.70 |
| EPS Diluted Continuous Ops | -4.04 | -3.04 | -3.58 | -3.19 | -2.64 |
| EPS Diluted Before Non-Recurring Items | N/A | -2.85 | -3.60 | -3.15 | -2.70 |
| EBITDA(a) | $-37,125 | $-27,604 | $-31,354 | $-27,683 | $-20,498 |